Categories: New Launches

Piramal Pharma Solutions Unveils its New cGMP Kilo Lab Suite for Active Pharmaceutical Ingredient (API) at Ennore, Chennai

Chennai, November 22, 2018: Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO) announced the completion of its new cGMP kilo lab suite at its API (Active Pharmaceutical Ingredient) site in Ennore, Chennai, India.The suite will formally open on December 1, 2018. Ennore is a key API site in the PPS integrated site network, with capabilities from early development through commercial manufacturing, with an available capacity of over 300kL. The site supplies Key Starting Materials, Registered Starting Materials, Advanced Intermediates and APIs for both large pharma and biotech firms, in North America, Europe, and RoW markets.

Anchored by a world-class R&D center, the cGMP kilo lab facility at Ennore will bridge the gap between Discovery and early Clinical development, addressing the needs of several discovery customers that want to rapidly advance their programs into the clinic. The facility operates in an ISO-8 certified clean room environment, with single fluid utility systems, supports temperatures ranging from -90°C to 200°C, and can handle batch sizes of up to 15 kg. Subsequent development and manufacturing of APIs as the programs advance, can be carried out at the Piramal sites in Riverview (USA), Aurora (Canada), Digwal (India), in addition to Ennore.

Vivek Sharma, Chief Executive Officer, Piramal Pharma Solutions said, “Ennore continues to grow in terms of customer interest. Recently, we have seen an increase in demand for stand-alone early cGMP development projects, further augmented by requests from our discovery customers, to support early clinical development API supply from India. By adding this new cGMP kilo lab, we can now supply Phase I clinical requirements throughseveralPiramal sites: Ennore, Riverview, and Aurora. With this kilo lab addition, we continue to offer choices to our partners, as they seek to advance projects from ‘Concept to Commercial’, all within the Piramal network.”

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Dr. Narendranadh Meda Introduces Esaote’s Cutting-Edge O-Scan MRI Machine to Enhance Podiatric (Foot and Ankle) care in Hyderabad

Hyderabad, December 26, 2024: Dr. Narendranadh Meda, one of the city’s leading Vascular, Endovascular &…

20 hours ago

A Breakthrough in India’s Medical Industry: Bangalore Hospitals Introduces the First 640 Slice CT Scan Imaging

Bangalore, December 26, 2024: Bangalore Hospitals, a renowned brand in healthcare innovation and quality, has introduced…

20 hours ago

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

6 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

6 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

7 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

7 days ago